Big Pharma Split (FRA:XN4) Altman Z-Score

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XN4 Big Pharma Split Corp FRA:XN4
7 GF Score
Price €6.90
GF Value €1.07
View Full Analysis

What is Big Pharma Split Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Altman Z-Score does not apply to banks and insurance companies.

FRA:XN4
7GF Score
Big Pharma Split Corp FRA:XN4
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Big Pharma Split (FRA:XN4) Overvalued in 2026?

Based on GuruFocus' analysis, Big Pharma Split stock appears to be overvalued. The current stock price of €6.90 is trading 544.9% above its estimated GF Value™ of €1.07.

Key valuation signals for FRA:XN4:

  • Altman Z-Score:
  • GF Value™: €1.07 vs. price of €6.90 (544.9% above fair value)
  • GF Score™: 7/100

No single metric tells the full story. See the FRA:XN4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Big Pharma Split Business Description

Other Exchanges PRM.PR.A.PFD:Canada
Address 610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a closed end mutual fund corporation. The investment objective of the company is to provide shareholders with fixed cumulative preferential quarterly cash distributions and regular monthly cash distributions. The company has a presence in the United States, France, and the United Kingdom.
7GF Score

Get the complete analysis for FRA:XN4

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.90
Price
€1.07
GF Value